<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00573846</url>
  </required_header>
  <id_info>
    <org_study_id>OCRT07005</org_study_id>
    <secondary_id>2007-5807</secondary_id>
    <nct_id>NCT00573846</nct_id>
  </id_info>
  <brief_title>Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US Study</brief_title>
  <official_title>Phenotypic Characteristics of Inflammatory Bowel Disease in Southeast Asian Population - A Multi-centered US Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Kentucky</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Health Resources</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jefferson Medical College of Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective, case control study of inflammatory bowel disease. This study will&#xD;
      analyze the phenotypic characteristics of inflammatory bowel disease in the Southeast Asian&#xD;
      population and will help describe clinical characteristics and serologic profiles in&#xD;
      Southeast Asians with inflammatory bowel disease, comparing the phenotype differences to&#xD;
      historical Caucasian controls. The data from this study will help identify the phenotype&#xD;
      characteristics of different ethnic groups and study the epidemiological patterns of the&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a retrospective, case control study of inflammatory bowel disease&#xD;
      characteristics in patients with origins from the Indian sub-continent. Patients will be&#xD;
      selected from the IBD registry maintained at respective institutions. Subjects from the&#xD;
      Indian sub-continent will be identified using their country of birth, parents' ethnicity,&#xD;
      number of years since leaving the country of birth, and number of years residing in the&#xD;
      United States.&#xD;
&#xD;
      Using both electronic and paper databases, demographic information regarding age, gender,&#xD;
      body mass index, smoking history, dietary habits; medical history such as type of IBD, IBD&#xD;
      symptoms, location and behavior, medication use (past and current), history of other&#xD;
      autoimmune disorders; surgical history (IBD and non-IBD related); laboratory indices such as&#xD;
      IBD serology, Thiopurinemethyltransferase (TPMT), and infliximab levels will be collected.&#xD;
&#xD;
      Demographics will be compared between groups using descriptive statistics. Using univariate&#xD;
      analysis, variables that are significantly different will be identified. Conditional logistic&#xD;
      regression will then be performed to identify those clinical variables that are statistically&#xD;
      significant.&#xD;
&#xD;
      The study duration will be one year from IRB approval.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Phenotypic characteristics of inflammatory bowel disease in southeast asian population</measure>
    <time_frame>12 months</time_frame>
    <description>Retrospective chart review</description>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected from the IBD registry maintained at respective institutions.&#xD;
        Subjects from the Indian sub-continent will be identified using their country of birth,&#xD;
        parents' ethnicity, number of years since leaving the country of birth, and number of years&#xD;
        residing in the United States.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with origins from the Indian sub-continent&#xD;
&#xD;
          -  Patients will be selected from the IBD registry maintained at respective institutions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nimisha K Parekh, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Irvine Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <study_first_submitted>December 12, 2007</study_first_submitted>
  <study_first_submitted_qc>December 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2007</study_first_posted>
  <last_update_submitted>January 26, 2015</last_update_submitted>
  <last_update_submitted_qc>January 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Nimisha Parekh</investigator_full_name>
    <investigator_title>Assistant Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>IBD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

